Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis

European Journal of Human Genetics

Volumn 18, Issue 7, 2010, Pages 827-831

  Alcina, Antonio ^a   Fernández, Óscar ^b   Gonzalez, Juan Ramón ^c   Catalá Rabasa, Antonio ^a   Fedetz, María ^a   Ndagire, Dorothy ^a   Leyva, Laura ^b   Guerrero, Miguel ^b   Arnal, Carmen ^d   Delgado, Concepción ^e   Lucas, Miguel ^f   Izquierdo, Guillermo ^f   Matesanz, Fuencisla ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e Centro Regional de Transfusión Sanguínea Granada Almería   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Association; GFI1 EVI5 RPL5 FAM69A genes; GWAS; Multiple sclerosis; Polymorphisms; Tag SNP analysis

Indexed keywords

ECOTROPIC VIRAL INTEGRATION SITE PROTEIN 5; FAMILY WITH SEQUENCE SIMILARITY PROTEIN 69; GENE PRODUCT; GROWTH FACTOR INDEPENDENT PROTEIN 1; RIBOSOMAL PROTEIN L5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; CHROMOSOME 1P; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RIBOSOMAL PROTEINS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 77953808270     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.240     Document Type: Article

References (22)

1. Compston A, Coles A: Multiple sclerosis. Lancet 2002; 359: 1221-1231.
2. Fernández O, Fernández V, Martinez-Cabrera V et al: Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association. Tissue Antigens 2008; 71: 426-433.
3. Alonso A, Jick SS, Olek MJ, Hernán MA: Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort. J Neurol 2007; 254: 1736-1741.
4. Lyndsay JW: Familiar recurrence rates and genetic models of multiple sclerosis. Am J Med Genet 2005; 135: 53-58.
5. McElroy JP, Oksenberg JR: Multiple sclerosis genetics. Curr Top Microbiol Immunol 2008; 318: 45-72.
6. Lundmark F, Duvefelt K, Iacobaeus E et al: Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113.
7. Gregory SG, Schmidt S, Seth P et al: Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
8. The International Multiple Sclerosis Genetics Consortium: Risk alleles for multiple sclerosis identified by a genome wide study. N Engl J Med 2007; 357: 851-862.
9. Kristjansdottir G, Sandling JK, Bonetti A et al: Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45: 362-369.
10. Matesanz F, Caro-Maldonado A, Fedetz M et al: IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J Neurol 2007; 254: 682-684.
11. Hoppenbrouwers IA, Aulchenko YS, Ebers GC et al.: EVI5 is a risk gene for multiple sclerosis. Genes Immun 2008; 9: 334-337.
12. Poser CM, Paty DW, Scheinberg L et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
13. Wigginton JE, Cutler DJ, Abecasis GR: A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 887-893.
14. González JR, Carrasco JL, Dudbridge F, Armengol L, Estivill X, Moreno V: Maximizing association statistics over genetic models. Genet Epidemiol 2008; 32: 246-254.
15. González JR, Armengol L, Solé X et al: SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 23: 644-645.
16. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995; 57: 289-300.
17. Sarkar SK: False discovery and false nondiscovery rates in single-step multiple testing procedures. Ann Stat 2006; 34: 394-415.
18. Rubio JP, Stankovich J, Field J et al: Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 2008; 9: 624-630.
19. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene): Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
20. Westlake CJ, Junutula JR, Simon GC et al: Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. Proc Natl Acad Sci USA 2007; 104: 1236-1241.
21. Richardson PM, Zon LI: Molecular cloning of a cDNA with a novel domain present in the tre-2 oncogene and the yeast cell cycle regulators BUB2 and cdc16. Oncogene 1995; 11: 1139-1148.
22. Faitar SL, Dabbeekeh JT, Ranalli TA, Cowell JK: EVI5 is a novel centrosomal protein that binds to alpha-and gamma-tubulin. Genomics 2005; 86: 594-605.